ANCA-associated Vasculitides

Also known as: Antineutrophilic cytoplasmic antibody [ANCA] vasculitis / ANCA-associated vasculitis / Antineutrophil cytoplasmic antibody positive vasculitis (disorder) / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00073	Rituximab	3	Completed	1